Interferons, immunity and cancer immunoediting - PubMed (original) (raw)
Review
doi: 10.1038/nri1961.
Affiliations
- PMID: 17063185
- DOI: 10.1038/nri1961
Review
Interferons, immunity and cancer immunoediting
Gavin P Dunn et al. Nat Rev Immunol. 2006 Nov.
Abstract
A clear picture of the dynamic relationship between the host immune system and cancer is emerging as the cells and molecules that participate in naturally occurring antitumour immune responses are being identified. The interferons (IFNs) - that is, the type I IFNs (IFNalpha and IFNbeta) and type II IFN (IFNgamma) - have emerged as central coordinators of tumour-immune-system interactions. Indeed, the decade-old finding that IFNgamma has a pivotal role in promoting antitumour responses became the focus for a renewed interest in the largely abandoned concept of cancer immunosurveillance. More recently, type I IFNs have been found to have distinct functions in this process. In this Review, we discuss the roles of the IFNs, not only in cancer immunosurveillance but also in the broader process of cancer immunoediting.
Similar articles
- Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.
Smyth MJ, Dunn GP, Schreiber RD. Smyth MJ, et al. Adv Immunol. 2006;90:1-50. doi: 10.1016/S0065-2776(06)90001-7. Adv Immunol. 2006. PMID: 16730260 Review. - Cytokines in cancer immunity and immunotherapy.
Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y. Smyth MJ, et al. Immunol Rev. 2004 Dec;202:275-93. doi: 10.1111/j.0105-2896.2004.00199.x. Immunol Rev. 2004. PMID: 15546400 Review. - Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response.
von Locquenghien M, Rozalén C, Celià-Terrassa T. von Locquenghien M, et al. J Clin Invest. 2021 Jan 4;131(1):e143296. doi: 10.1172/JCI143296. J Clin Invest. 2021. PMID: 33393507 Free PMC article. Review. - Cancer despite immunosurveillance: immunoselection and immunosubversion.
Zitvogel L, Tesniere A, Kroemer G. Zitvogel L, et al. Nat Rev Immunol. 2006 Oct;6(10):715-27. doi: 10.1038/nri1936. Epub 2006 Sep 15. Nat Rev Immunol. 2006. PMID: 16977338 Review. - IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Santini SM, Lapenta C, Santodonato L, D'Agostino G, Belardelli F, Ferrantini M. Santini SM, et al. Handb Exp Pharmacol. 2009;(188):295-317. doi: 10.1007/978-3-540-71029-5_14. Handb Exp Pharmacol. 2009. PMID: 19031032 Review.
Cited by
- Long-term prognosis and treatment modalities of hepatic epithelioid hemangioendothelioma: a retrospective study of 228 patients.
Liu X, Yang P, Liu L, Si S, Zhou R, Liu T, Tan H. Liu X, et al. BMC Cancer. 2024 Oct 16;24(1):1285. doi: 10.1186/s12885-024-13053-4. BMC Cancer. 2024. PMID: 39415114 Free PMC article. - Novel prognostic model of complement and coagulation cascade-related genes correlates with immune environment and drug sensitivity in hepatocellular carcinoma.
Su H, Chen Y, Wang W. Su H, et al. Heliyon. 2024 Sep 20;10(19):e38230. doi: 10.1016/j.heliyon.2024.e38230. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39391504 Free PMC article. - Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood.
Orcutt-Jahns B, Lima Junior JR, Lin E, Rockne RC, Matache A, Branciamore S, Hung E, Rodin AS, Lee PP, Meyer AS. Orcutt-Jahns B, et al. NPJ Syst Biol Appl. 2024 Oct 10;10(1):118. doi: 10.1038/s41540-024-00447-0. NPJ Syst Biol Appl. 2024. PMID: 39389979 Free PMC article. - Arrest and Attack: Microtubule-Targeting Agents and Oncolytic Viruses Employ Complementary Mechanisms to Enhance Anti-Tumor Therapy Efficacy.
De S, Ehrlich M. De S, et al. Genes (Basel). 2024 Sep 11;15(9):1193. doi: 10.3390/genes15091193. Genes (Basel). 2024. PMID: 39336785 Free PMC article. Review. - Investigation of pre and postoperative Th1/Th2 cytokine balance and novel cytokines in colorectal cancer patients.
Gülçek E, Aydoğdu YF, Emreol Uİ, Bağrıaçık EÜ, Akyürek N. Gülçek E, et al. Clin Exp Med. 2024 Sep 4;24(1):211. doi: 10.1007/s10238-024-01480-3. Clin Exp Med. 2024. PMID: 39230623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources